Editor profile
Director, International Health Policy
Sophia Rossi monitors global healthcare regulations, insurance reimbursement models, and digital health compliance. She specializes in the evolving regulatory frameworks of the EMA and FDA.
sophia.rossi@medtechdaily.orgAccording to the latest report from Precedence Research, the global digital health market size is expected to grow from $420.08 billion in 2025 to $1.171 trillion by 2035, with a CAGR of 10.8%. AI, telemedicine, and wearable devices are driving the wave of healthcare digitalization, with Europe leading the global market.
The global medical device market was valued at $537.38 billion in 2025 and is expected to reach $826.53 billion by 2034. The integration of population aging and AI technology is reshaping the industry landscape, with minimally invasive surgery and remote monitoring becoming growth highlights.
The leadership in medical technology innovation is shifting from large enterprises to private and mid-sized companies, with R&D investment, clinical trials, and approval data revealing new industry trends.
This article is based on Salesforce's latest industry insights, analyzing the core applications, industry trends, market impact, and potential challenges of AI in healthcare, and exploring the industrial path of medical AI evolving from an assistive tool to healthcare system infrastructure.
According to Market.us Media data, the global digital health market is expected to reach $2.19 trillion by 2034, with $287.8 billion in 2024, representing a compound annual growth rate of 22.5%. North America dominates the market, while Asia-Pacific is growing the fastest, with telemedicine, medical AI, and wearable devices becoming core drivers.
The global wearable medical device market is expected to reach $167.8 billion by 2035, with a compound annual growth rate of 14.2%. Driven by policy, technology, and capital, the healthcare industry is undergoing a transition from periodic checkups to continuous monitoring.
Medical AI has moved from experimentation to clinical practice, but the practical application of diagnosis, treatment, and decision support still faces challenges in data, trust, and integration. This article reviews the current state and future trends.
The digital health market is expected to grow from $287.8 billion in 2024 to $2.19 trillion by 2034, with a compound annual growth rate of 22.5%. North America leads with a 38.4% share, while Asia-Pacific is the fastest-growing region. Technological innovations such as AI, telemedicine, and wearable devices are reshaping the healthcare industry landscape. This article provides an in-depth analysis of market trends, regional dynamics, and future opportunities.
The global life science tools market is being redefined by automation, data science, and precision medicine. Reports project the market will reach $455 million by 2034, with a compound annual growth rate of 10.36%.
Heidi Health's "Pressure Points 2026" report shows that 83% of clinicians have already adopted ambient AI documentation tools on their own before their institutions establish formal AI governance frameworks, in response to the growing burden of medical documentation.
A study by the American Medical Association shows that most doctors believe data from consumer wearable devices (such as smartwatches) have clinical value, but issues such as accuracy, liability, and data integration still hinder their widespread adoption.
Analyze the event of Veradigm being sued for patient portal data tracking, and explore the challenges and industry impacts of medical technology companies in data sharing and privacy compliance.
In the third quarter of 2026, the FDA will make approval decisions on multiple biotechnology products, involving areas such as IgA nephropathy, mRNA influenza vaccines, Duchenne muscular dystrophy cell therapy, and gene therapy. These decisions will profoundly impact the direction of the medical technology industry.
ZS Impact Institute report shows 90% of consumers trust AI health advice as much as that of doctors, early diagnosis could save $500 billion, promoting a zero-distance care model.
2026 US Digital Health Laws and Regulations Update, covering digital health technology, data use and sharing, and analysis of impacts on medical technology companies, hospitals, and investors.
GE HealthCare will showcase AI software, imaging systems, radiopharmaceuticals, and localized production solutions related to nuclear medicine during SNMMI 2026, reflecting that nuclear medicine is moving from competition among single devices toward a phase of expansion driven by “platformization + ecosystemization.”
Siemens Healthineers is partnering with AiM Medical Robotics to integrate MRI scanning with a neurosurgical robotic platform; meanwhile, Procept BioRobotics has completed enrollment in a randomized study on prostate cancer. Together, these two developments point to a trend: medical device companies are accelerating their entry into more high-barrier treatment settings through image guidance, robotic systems, and clinical trials.